Current Possition: Professor of Skin Integrity and Clinical Nursing.
Dimitri Beeckman is a Professor of Skin Integrity and Clinical Nursing at Ghent University and holds visiting professorships at the University of Surrey (UK), the Royal College of Surgeons in Ireland (Ireland), the University of Southern Denmark (Denmark), and Örebro University (Sweden). In 2012 and 2013, he was project leader of the development of the Belgian National Pressure Ulcer Prevention and Treatment Guidelines. This government project was funded by the Belgian Healthcare Knowledge Centre (KCE) in close collaboration with the UK National Clinical Guideline Centre (the developers of the NICE guidelines).
In 2012, he introduced an international working group focusing on incontinence- associated dermatitis (prevention and treatment). This working group consisted of experts (clinicians, researchers) from the US, Germany, Belgium, the UK, and the Netherlands. The small working group formed the basis for the development of the IAD International Research group. As chair of this group, he developed a Cochrane review to focus on the evidence supporting the effectiveness of products/procedures to prevent/treat IAD. His research on IAD is ground breaking and let to specific insights into the association between IAD and pressure ulcers. He currently leads research about the development of a specific core outcome set for international IAD research. This research is conducted in close collaboration with the Department of Dermatology at Ghent University Hospital and the Charité - Universitätsmedizin Berlin in Germany. Besides, his team developed the Global IAD Severity Categorization Tool (GLOBIAD) and a tool to assess the healing of skin lesions caused by incontinence. This research is performed in close collaboration with partners from 13 countries. In 2015, he published (in collaboration with Wounds International) the Global Expert document on the Prevention and Treatment of Incontinence-Associated Dermatitis. The document is translated in 13 different languages and new translations are ongoing. He was invited by the International Continence Society (ICS) to write a chapter about Skin Health and Incontinence Products for the 5th International Consultation on Incontinence. Since 2013 he holds several leadership positions in European and global organisations focusing on skin integrity research, practice, education and policy making.
He acts as a policy advisor for the Federal government for the development of indicators to assess the quality of nursing care. Since 2018, he is President- Elect of both the European Pressure Ulcer Advisory Panel (EPUAP) and the International Skin Tear Advisory Panel (ISTAP). He is the scientific coordinator of the Skin Integrity Research Group (SKINT, www.skintghent.be) at Ghent University.
Recent research includes risk factors studies in multiple settings (acute care and hospital), clinical trials with support surfaces to prevent pressure ulcers in high- risk populations, the development and psychometric validation of tools to assist implementation of best practices in a variety of clinical settings, epidemiological research in multiple settings in patients with a variety of skin conditions, laboratory studies focusing on histopathology of pressure ulcers and IAD (in collaboration with the Dermatology Department at Ghent University), the development of Core Outcome Sets for both pressure ulcer and IAD research, etc. In 2017, he published with his team the first ever Core Outcome Set for clinical trials for a nurse-led clinical condition (IAD).
Through his wide international network of researchers, clinicians and policy makers, he increases awareness for pressure ulcers as a global health issue and he convinces governments to designate pressure ulcers as one of the most important sentinel events for health care.
Five main publications
1. Van den Bussche K, Kottner J, Beele H, De Meyer D, Dunk AM, Ersser S, Lange T, Petrovic M, Schoonhoven L, Smet S, Van Damme N, Verhaeghe S, Van Hecke A, Beeckman D. Core outcome domains in incontinence-associated dermatitis research. Journal of Advanced Nursing 2018 Jul;74(7):1605-1617. (IF: 2.267, Ranking in category Nursing: 7/118)
2. Van Damme N, Clays E, Verhaeghe S, Van Hecke A, Beeckman D. Independent risk factors for the development of incontinence-associated dermatitis (category 2) in critically ill patients with fecal incontinence: A cross-sectional observational study in 48 ICU units. International Journal of Nursing Studies. 2018 May;81:30-39. (IF: 3.656, Ranking in category Nursing: 1/118)
3. Beeckman D, Van den Bussche K, Alves P, Arnold Long MC, Beele H, Ciprandi G, Coyer F, de Groot T, De Meyer D, Deschepper E, Dunk AM, Fourie A, García-Molina P, Gray M, Iblasi A, Jelnes R, Johansen E, Karadağ A, Leblanc K, Kis Dadara Z, Meaume S, Pokorna A, Romanelli M, Ruppert S, Schoonhoven L, Smet S, Smith C, Steininger A, Stockmayr M, Van Damme N, Voegeli D, Van Hecke A, Verhaeghe S, Woo K, Kottner J. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries. British Journal of Dermatology. 2018 Jun;178(6):1331-1340. (IF: 6.129, Ranking in category Dermatology: 4/64)
4. Beeckman D, Van Damme N, Schoonhoven L, Van Lancker A, Kottner J, Beele H, Gray M, Woodward S, Fader M, Van den Bussche K, Van Hecke A, De Meyer D, Verhaeghe S. Interventions for preventing and treating incontinence-associated dermatitis in adults. Cochrane Database Syst Rev. 2016 Nov 10;11:CD011627. (IF: 6.754, Ranking in category Medicine, General and Internal: 13/155)
5. Van Damme N, Van den Bussche K, De Meyer D, Van Hecke A, Verhaeghe S, Beeckman D. Independent risk factors for the development of skin erosion due to incontinence (incontinence-associated dermatitis category 2) in nursing home residents: results from a multivariate binary regression analysis. International Wound Journal. 2017 Oct;14(5):801-810. (IF: 2.380, Ranking in category Dermatology: 22/64)
Other scientific output
Dimitri Beeckman is currently the chief investigator of a large publically funded randomized controlled clinical trial (2 750 000 EURO) entitled: “The use of a silicone adhesive multilayer foam dressing as an adjuvant prophylactic therapy for pressure ulcer prevention: a multicentre randomised open label parallel group medical device trial in hospitalised patients at risk for pressure ulcer development.” This multicentre study is performed in 8 hospitals in Belgium.